Scorpion Secures $150M in Series C Funding to Expand Cancer Pipeline Clinical Plans

July 18, 2024

AI Firm Formation Bags $372 Series D Funding

June 30, 2024

Vertex reduces scope of near-term Journavx development after FDA rejection

August 12, 2025

Must Read

The Future of AI-Assisted Clinical Operations

July 24, 2026

BeOne Invests $300 Million to Add Small Molecule Manufacturing at New Jersey Campus

July 24, 2026

Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims

July 23, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Summit and Akeso Report Updated HARMONi Survival Data for Ivonescimab in Western NSCLC Patients

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Biogen’s Phase 2 Diranersen Data Shows Reduced Cognitive Decline in Alzheimer’s Disease

ARPA-H Awards Up to $160 Million for Personalized Genetic Medicine Development

Due to poor phase 2 data, Agios declares goodbye to the sickle cell program

Novartis Lets Go of Phase 2 Radioligand Therapy Following Clinic Disappointment

Bausch + Lomb Ends BL1107 Glaucoma Program After Phase 2 Trial Misses Main Goal

Ionis and AstraZeneca falter as the ATTR-CM medication fails Phase 3

BeOne Invests $300 Million to Add Small Molecule Manufacturing at New Jersey Campus

GSK views the Hansoh-partnered ADCs’ phase 3 victory in China as confirming its “priority asset.”

Vogenx Files for a Nasdaq Capital Market IPO to Fund Metabolic Drug

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

The Future of AI-Assisted Clinical Operations

The End of Siloed Drug Development

Top 10 Reasons Commercial AI Requires Stronger Governance in Pharma

Top 10 Metrics Pharma Leaders Should Track During Digital Transformation

Tag: Clinical Operations

The Future of AI-Assisted Clinical Operations

Editor Picks

Scorpion Secures $150M in Series C Funding to Expand Cancer Pipeline Clinical Plans

AI Firm Formation Bags $372 Series D Funding

Vertex reduces scope of near-term Journavx development after FDA rejection

Must Read

The Future of AI-Assisted Clinical Operations

BeOne Invests $300 Million to Add Small Molecule Manufacturing at New Jersey Campus

Novo Nordisk Sues Eli Lilly Over GLP-1 Drug Advertising Claims

Hot Topics

About Us

Follow Us